<DOC>
	<DOCNO>NCT00399295</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetic ( way drug enters leave blood tissue time ) profile Dilaudid OROS 16mg ( Dilaudid Slow Release ; hydromorphone HCL ) administer fasting condition , follow high-fat breakfast meal . The study also examine effect naltrexone blockade pharmacokinetic profile Dilaudid SR .</brief_summary>
	<brief_title>An Open-Label Evaluation Independent Effects Coadministration High-Fat Meal Naltrexone Blockade Pharmacokinetic Profile Dilaudid OROS ( Hydromorphone HCI ) 16mg</brief_title>
	<detailed_description>This randomize ( patient assign different treatment base chance ) , open-label , three-way crossover study , perform normal , healthy adult . Each patient receive orally administer treatment ( different treatment dose phase ) : Treatment A : single dose Dilaudid SR 16 mg administer fasting condition without naltrexone block ; Treatment B : single dose Dilaudid SR 16 mg administer fed condition without naltrexone block , Treatment C : single dose Dilaudid SR 16 mg administer fasting condition naltrexone HCL 50mg block ( 3 oral dos 50mg administer 12 hour prior , time , 12 hour Dilaudid SR 16mg administration ) . There 7-day washout period dose phase . Venous blood sample time 0 ( prior dosing ) ,2,4,6,8,10,12,16,20,24,30,36,42 , 48 hour Dilaudid SR administration . LC/MS/MS ( Liquid Chromatography/Mass Spectroscopy/Mass Spectroscopy ) techniques employ analysis plasma hydromorphone concentration . Each patient randomly receive orally-administered treatment single dose Dilaudid SR 16mg ; fast condition without naltrexone block ; feed condition without naltrexone block ; fast condition naltrexone 50mg block ( 3 oral dos 50mg naltrexone HCL administer 12 hour prior , time , 12 hour hydromorphone administration ) ; 7-day washout period dose phase .</detailed_description>
	<mesh_term>Hydromorphone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Narcotic Antagonists</mesh_term>
	<criteria>Patients nonsmoking , healthy volunteer body weight 135 220 pound within + 10 % recommend weight range height body frame accord 1984 Metropolitan Height Weight Tables A negative baseline urine drug screen cannabinoids , opiate , cocaine , ethanol barbiturate . Patients intolerant hypersensitive hydromorphone naltrexone Patients gastrointestinal disorder may affect absorption orally administer drug Patient depress respiratory function Patient impair renal hepatic function Patients dependence opiates Pregnant breast feed Female Patients childbearing potential must negative pregnancy test week prior administration study drug require follow medically recognize contraceptive program prior study .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Analgesia</keyword>
</DOC>